Hovione

Hovione is a globally operating, privately-held CDMO specializing in complex small molecule drug development and manufacturing. It has established itself as a leader in advanced drug delivery technologies, most notably in spray drying for amorphous solid dispersions (to overcome drug solubility issues) and in the formulation of inhaled and nasal therapies. With a significant track record in cGMP compliance and a 'one-site solution' for integrated services, Hovione positions itself as a critical partner for pharmaceutical companies seeking to de-risk and accelerate the development of challenging molecules. The company's deep technical expertise, multi-continent manufacturing footprint, and patient-centric values underpin its long-standing reputation in the industry.

Specialist integrated CDMO with core expertise in spray drying for amorphous solid dispersions (solubility enhancement), inhalation/nasal drug product engineering, microencapsulation, and continuous tableting.

Operates in the competitive global CDMO market, competing with large, diversified players (e.g., Lonza, Catalent) and other specialist firms. Its differentiation lies in deep expertise in niche areas like spray-dried dispersions and integrated inhalation services, where it is considered a leader.